Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Asset Utilization Ratio (2016 - 2025)

China Pharma Holdings filings provide 15 years of Asset Utilization Ratio readings, the most recent being 0.18 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 44.57% to 0.18 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.18, a 44.57% decrease, with the full-year FY2025 number at 0.18, down 37.47% from a year prior.
  • Asset Utilization Ratio hit 0.18 in Q4 2025 for China Pharma Holdings, down from 0.27 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.56 in Q1 2021 to a low of 0.18 in Q4 2025.
  • Median Asset Utilization Ratio over the past 5 years was 0.43 (2022), compared with a mean of 0.42.
  • Biggest five-year swings in Asset Utilization Ratio: grew 28.07% in 2021 and later crashed 44.57% in 2025.
  • China Pharma Holdings' Asset Utilization Ratio stood at 0.47 in 2021, then grew by 0.98% to 0.48 in 2022, then decreased by 7.6% to 0.44 in 2023, then dropped by 27.5% to 0.32 in 2024, then plummeted by 44.57% to 0.18 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.18 (Q4 2025), 0.27 (Q3 2025), and 0.31 (Q2 2025) per Business Quant data.